Development of an Antiviral Ion-Activated In Situ Gel Containing 18β-Glycyrrhetinic Acid: A Promising Alternative against Respiratory Syncytial Virus

The human respiratory syncytial virus (hRSV) is a major cause of serious lower respiratory infections and poses a considerable risk to public health globally. Only a few treatments are currently used to treat RSV infections, and there is no RSV vaccination. Therefore, the need for clinically applica...

Descripción completa

Detalles Bibliográficos
Autores principales: Özkan, Burcu, Altuntaş, Ebru, Ünlü, Ümmühan, Doğan, Hasan Hüseyin, Özsoy, Yıldız, Çakır Koç, Rabia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458153/
https://www.ncbi.nlm.nih.gov/pubmed/37631269
http://dx.doi.org/10.3390/pharmaceutics15082055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458153/
https://www.ncbi.nlm.nih.gov/pubmed/37631269
http://dx.doi.org/10.3390/pharmaceutics15082055

Ejemplares similares